MENNINI Francesco Saverio

Aggregate Professor

Affiliation: Department of Economics and Finance (DEF) - University of Tor Vergata

Other Affiliation:
SIHTA (Italian Society of Health Technology Assessment. President), IHEA (International Health Economics Association), AIES (Italian Association of Health Economics), ISPOR (International Society for Pharmacoeconomics and Outcome Research. President from 2014 to 2017), SIHTA (Italian Society of Health Technology Assessment. Member of the Scientific Commettee), HTAi (Health Technology Assessment International), IHPMI (International Health Policy and Management Institute), ISPE Sanità (Institute for study on corruption in the Health Sector).

Address: via Columbia n. 2, 00133 Roma

Telephone: +39 06 7259 5642

Research Interests:
Health economics, HTA, Pharmacoeconomics, Pharmaceutical Economics, Corruption and Health, Health System comparison

Biography

Prof. Francesco Saverio Mennini, is presently Professor for Health Economics and Economics (Business Administration Course) at University of Rome "Tor Vergata” (Faculty of Economics). He is also Professor for Political Economics at University of Rome "Tor Vergata”, Faculty of Science. Visiting Professor, Institute of Leadership and Management in Health, Kingston University, London, UK (from 2011).

  • Research Director, Health Economics and Management (HEM) | Economic Evaluation and HTA (EEHTA), CEIS - Faculty of Economics, University of Rome “Tor Vergata”.
  • President, SiHTA (Italian Society of Health Technology Assessment).
  • Past President, ISPOR Italy Rome Chapter.
  • Formerly, he has led a career as a researcher in the field of Health Economics and Industrial Economics, at the University of Rome "Tor Vergata” and the National Research Council.
  • His main contributions have dealt with Health Technology Assessment (HTA) and Pharmaco-economics, Welfare policies, health system analysis, and pharmaceutical economics.
  • Prof. Mennini has been the scientific coordinator of the Master in Health Economics at University of Rome "Tor Vergata for several years; he has been a scientific coordinator and member of the Regional Observatory for the HTA, from 2003 to 2006.
  • Prof. Mennini has been the chair of the Scientific Committee of the European Conference on Health Economics (ECHE).
  • Prof. Mennini is member of Regional Scientific Commettee on HIV and HCV (from 2011).
  • Prof. Mennini is member, as economists expert, of Consiglio Superiore di Sanità. (from 2017).
  • Prof. Mennini is author of numerous publications, national and international, of Health Economics, HTA and Economic Evaluation.

Publications

  • Trabucco Aurilio M, Mennini FS, Nardone C, Piccioni A, Bolcato M, Russo V, Sciannamea V, Migliorini R, Coppeta L, Magrini A. The Health and Economic Impact of Atrial Fibrillation: Social Security Benefits for Workers in Italy. Int. J. Environ. Res. Public Health 2022, 19, 1883. https://doi.org/10.3390/ijerph19031883. (IF: 3.390).
  • Gruppo di lavoro “Consensus sulle terapie psicologiche per ansia e depressione”. Consensus Conference sulle terapie psicologiche per ansia e depressione”. Roma: Istituto Superiore di Sanità; 2022. (Consensus ISS1/2022). 
  • Mennini FS, Magni D, Daniele L, Favato G. Knowledge management in turbulent times: time-based scenario analysis of vaccinations against COVID-19. Journal of Knowledge Management,. (2021). (IF: 8.182).
  • Mennini, FS, Gori M, Vlachaki I et al. Cost-effectiveness analysis of Vaborem in Carbapenem-resistant Enterobacterales (CRE) -Klebsiella pneumoniae infections in Italy. Health Econ Rev 11, 42 (2021). https://doi.org/10.1186/s13561-021-00341-z. 2021. (IF: 2.502).
  • Pontieri P,  Mennini FS,  Magni M, Fiano F, Scuotto V, Papa A, Aletta M, Del Giudice L, Sustainable Open Innovation for Agri-Food system. Sorghum as healthy food to deal with environmental challenges. Britsh Food Journal (2021) (IF: 2.518).
  • Mennini FS, Trabucco Aurilio M, Gazzillo S, Nardone C, Sciattella P, Marcellusi A, Migliorini R, Sciannamea V, Piccioni A, Bolcato M, Barni S. An Analysis of the Social and Economic Costs of Breast Cancer in Italy. Int. J. Environ. Res. Public Health 2021, 18, 9005. 2021. (IF: 3.390).
  • Trabucco Aurilio M, Mennini FS, Gazzillo S, Massini L, Bolcato M, Feola A, Ferrari C, Coppeta L. Intention to Vaccinate For COVID-19 Among Italian Nurses During the Pandemic. Vaccines 2021, 9, 500. 2021. (IF: 4.422).
  • Mennini FS, Fabiano G, Favato G, Sciattella P, Bonanni P, Pinto C, Marcellusi A, Economic burden of HPV9-related diseases: a real-world cost analysis from Italy, (Original Article), The European Journal of Health Economics, 2019 (IF:2.367).
  • Mennini FS, Marcellusi A, Robbins Scott S, Montilla S, Craxi A, Buti M Gheorghe L, Ryder S and Kondili L, The impact of direct acting antivirals on hepatitis C virus disease burden and associated costs in four european countries. ORIGINAL ARTICLE. Liver International, 2021;00:1-15. DOI:10.1111/liv.14808. (IF: 5.542)
  • Mennini FS, Dallapiccola B., Moriconi S., Rota A., Barbagallo M., Giuastina A., et al., Patologia ortopedica nelle condizioni di fragilità. Ministero della Salute. (Documento del Gruppo di Lavoro presso Consiglio Superiore di Sanità). 2021.
  • Bellantone R, Moriconi S, Gensini G, Mennini FS, Bramanti P, Miragliotta F, et al., Strategia, Principi attuativi ed Analisi dell’impatto socio-economico del Percorso Ictus in Italia. Ministero della Salute. (Documento del Gruppo di Lavoro presso Consiglio Superiore di Sanità). 2021.
  • Dallapiccola, B, Mennini FS, Moriconi S, Barbagallo M, Di Giulio P, Longo F, et al., Invecchiamento della popolazione e sostenibilità del SSN: il ruolo della Health Technology Assessment (HTA) per la valutazione tecnica, economica ed organizzativa della Sanità del futuro. Ministero della Salute (Documento del Gruppo di Lavoro presso Consiglio Superiore di Sanità). 2021.
  • Lawler M, De Lorenzo F, Lagergren P, Mennini FS, Narbutas S, Scocca G, Meunier F, on behalf of the European Academy of Cancer Sciences. Delineating the challenges and identifying solutions to embed cancer survivorship research and innovation within the EU Cancer Mission. Molecular Oncology, 15 (2021) 1750–1758, 2021. (IF: 6.574). 2021 
  • Kondili LA, Gamkrelidze I, Blach S, Marcellusi A, Galli M, Petta S, Puoti M, Vella S, Razavi H, Craxi A, Mennini FS, on behalf of the PITER collaborating group. Optimization of hepatitis C virus screening strategies by birth cohort in Italy. ORIGINAL ARTICLE. Liver International. 2020; 00:1–11. John Wiley & Sons Ltd (IF: 5.542). 2020 
  • Mennini FS, Luciani A, Gitto L, Waste and Corruption in Health Care. Chapter 14 in : “Corruption in the Global Era. Causes, Sources and Forms of Manifestation”, By Lorenzo Pasculli, Nicholas Ryder. ISBN 9780367660550. Published September 30, 2020 by Routledge. 2020.
  • Vardé A, Mennini FS. Il personale del Servizio Sanitario Nazionale - evoluzione e prospettive nella programmazione sanitaria. Issue: 110, Pg. 9-43,DOI: 10.3280/MESA2019-110002, 2019. (IF:0.14). 2019.

More CEIS Publications »

Events & Presentations

  • 2021. Mennini FS (Session Chair and presenter), Favato G, Nardone C, Parallel Session, The Economic and Social Value of Prevention, 62nd Annual Conference - Italian Economic Association (SIE), 26-29 October, 2021.
  • 2021. Tangri, J. Ärnlöv, M.C. Batista, S. Chadban, G.M. Chertow, L. De Nicola, J.-M. Halimi, E. Kanda, G. Li, FS Mennini, J.F. Navarro-González, A. Power, A.A. Sultan, L. Webber, J. Wish. Inside CKD: modelling the future global burden of chronic kidney disease in patients with type 2 diabetes. EASD, 57th annual meeting, 27 September – 1 October 2021. (oral Presentation).
  • 2021. Nolan, J. Ärnlöv, M.C. Batista, S. Chadban, G.M. Chertow, L. De Nicola, J.-M. Halimi, E. Kanda, G. Li, FS Mennini, J.F. Navarro-González, A. Power, L. Reta, N. Tangri, J. Wish. Inside CKD: modelling the clinical and economic impact of routine screening for albuminuria in people with type 2 diabetes. EASD, 57th annual meeting, 27 September – 1 October 2021. (oral Presentation).
  • 2021. Power, J. Ärnlöv, M.C. Batista, J. Card-Gowers, S. Chadban, G.M. Chertow, L. De Nicola, J.-M. Halimi, E. Kanda, G. Li, FS Mennini, J.F. Navarro-González, J.J.G. Sanchez, N. Tangri, J. Wish. Inside CKD: modelling the direct economic burden of concomitant chronic kidney disease and type 2 diabetes. EASD, 57th annual meeting, 27 September – 1 October 2021. (oral Presentation).
  • 2020. C Nardone, R Migliorini, V Sciannamea, M Trabucco Aurilio, FS Mennini. The Economic Analysis of Social Security Costs Cancer-Related in Italy. International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual Conference. 16-19 Novembre 2020.
  • 2020. Mennini FS et al., Estimating the Fiscal Consequences of Investments in Disease-Modifying Therapies for the Treatment of Relapsing-Remitting Multiple Sclerosis in Italy. International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual Conference. 16-19 Novembre 2020.
  • 2020. Rossi D, Mennini FS e Marcellusi A. Economic impact of Q6W dosing regimen of Pembrolizumab in Advanced or Adjuvant Melanoma. International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual Conference. 16-19 Novembre 2020.
  • 2020. Mennini FS, Sciattella P, Nardone C. La mobilità sanitaria in Italia: i fattori causali e le relative determinanti. 61st Annual Conference the Italian Economic Association (SIE). 20-23 Ottobre 2020.
  • 2020. Marcellusi A, Mennini FS, Chiara Bini, Martina Paoletti. THE OPPORTUNITY COST OF HPV9 VACCINATION IN ITALY. Convegno Annuale Società Italiana di HTA (SiHTA), Roma, 26-30 Ottobre 2020.
  • 2020. Gazzillo S, Nardone C, Mennini FS. Costi assistenziali della cecità in Italia. Analisi di dati amministrativi per una valutazione economico-sanitaria. Convegno Annuale Società Italiana di HTA (SiHTA), Roma, 26-30 Ottobre 2020.
  • 2020. Mennini FS, Sciattella P. Calcolosi renale analisi su dati amministrativi per misurare il burden delle calcolosi renali in Italia. Convegno Annuale Società Italiana di HTA (SiHTA), Roma, 26-30 Ottobre 2020.
  • 2020. Bini C, Mennini FS, Rotundo MA, Marcellusi A, Antinori A, Gagliardini R, Sarmati L, Andreoni Costo-Efficacia dello screening per l'HIV sulla popolazione adulta in Italia. Convegno Annuale Società Italiana di HTA (SiHTA), Roma, 26-30 Ottobre 2020.
  • 2020. Mennini FS. Nuovi schemi di valutazione impatto economico delle malattie rare: rischio atteso e investimento. (Sessione Tematica). Convegno Annuale Società Italiana di HTA (SiHTA), Roma, 26-30 Ottobre 2020.
  • 2020. Mennini FS. Sanità come investimento: impatto sociale e previdenziale. (Sessione Plenaria). Ruolo fondamentale dei Costi Indiretti e Sociali. Convegno Annuale Società Italiana di HTA (SiHTA), Roma, 26-30 Ottobre 2020.

Research Programs & Projects

  • Research Coordinator “ Osservatorio sui Dispositivi Medici in Italia (evidenze dell’impatto economico)” financed by Confindustria Dispositivi Medici. 2020 
  • Research Coordinator: “Proposta per l’attuazione di iniziative di contrasto alle fake news nel settore sanitario (evidenze dell’impatto economico)”, financed by Ministero della Salute, Direzione Generale della Comunicazione. 2019 
  • Research Coordinator: “Il ruolo dell’adozione di pratiche assistenziali e dei dispositivi medici innovativi di comprovata efficacia clinica nella prevenzione e riduzione dell’insorgenza delle Infezioni Ospedaliere”. Financed by Ministero della Salute, Direzione Generale dei Dispositivi Medici e del Servizio Farmaceutico. 2019
  • Research Coordinator: “La qualità e l’accessibilità ai servizi sanitari: le determinanti della mobilità sanitaria nelle regioni in piano di rientro”, financed by Ministero della Salute, Direzione Generale Della Programmazione Sanitaria. 2018 
  • Research Coordinator: “Invecchiamento della popolazione attiva: studio dell’impatto delle patologie cronico-degenerative e oncologiche sul contesto sociale, demografico, epidemiologico ed economico sanitario italiano, attraverso la costruzione di modelli di stima dei costi e di scenari previsionali”. Financed by per INAIL - Bando di ricerche in collaborazione - Piano attività della ricerca discrezionale 2016-2018.
  • Research Coordinator: “La valutazione dei costi indiretti per una migliore programmazione regionale e aziendale”, financed by Ministero della Salute, Direzione Generale dei Dispositivi Medici e del Servizio Farmaceutico. 2017 
  • Research Coordinator "DISPOSITIVI MEDlCI E COSTI DI RICOVERO: LA DETERMINAZIONE DEL PESO SULLE TARIFFE PER UNA MIGLIORE PROGRAMMAZIONE REGIONALE E AZIENDALE”, Project financed by Italian Ministry of Health, 2011-2013.
  • Research Coordinator CORSO DI FORMAZIONE: LA DIFFUSIONE E GESTIONE DEI DISPOSITIVI MEDICI A LIVELLO AZIENDALE, Project financed by Italian Ministry of Health, 2011-2013.
  • Research Coordinator of COST OF ILLNESS ANTI-HYPERTENSIVE THERAPY. Estimated direct and indirect costs attributable to the non-compliance with anti-hypertensive therapy. Reserach Project financed by Daiichi-Sankyo Europe. 2012-2013.
  • Advisory Board member, inexpert of Health Economics, "Unhealthy Health System - Promoting integrity in the health service and implementino check and balance evaluation", project assigned to Transparency International Italia (TI-It) from European Commission DG-Home Affairs. 2012-2013. 
Back